Phaseline

Targets › AG

AG: drug programs, companies and trials

1 program from 1 company in 2 trials: 2 Phase 2; Gastroenterology; next expected readout Aug 2027.

Open in Phaseline: the race on AG, likelihood bands and readouts

Programs

CompanyDrugTargetsHighest phaseConditionsNext expected readout
The University of Hong KongSilver diamine fluoride gel
Silver and fluoride-based antimicrobial and remineralization agent for caries arrest
AGPhase 2Early Childhood Caries; Early Childhood Caries (ECC)Aug 2027

Conditions

Early Childhood Caries (1) Early Childhood Caries (ECC) (1)

Modalities

small molecule (1)

Companies

The University of Hong Kong (1)

Related targets

–

Programs group each company's trials by drug; targets and mechanisms come from Open Targets and ChEMBL via Open Targets; expected readouts are Phaseline's estimate from the registry's primary completion date. Facts from the registries only; the approval likelihood is in the app.